Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tie2 regulates endocardial sprouting and myocardial trabeculation
Xianghu Qu, Cristina Harmelink, H. Scott Baldwin
Xianghu Qu, Cristina Harmelink, H. Scott Baldwin
View: Text | PDF
Research Article Cardiology Development

Tie2 regulates endocardial sprouting and myocardial trabeculation

  • Text
  • PDF
Abstract

The ang1-tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie2) pathway is required for normal vascular development, but its molecular effectors are not well-defined during cardiac ontogeny. Here, we show that endocardial-specific attenuation of Tie2 results in midgestation lethality due to heart defects associated with a hyperplastic but simplified trabecular meshwork (fewer but thicker trabeculae). Reduced proliferation and production of endocardial cells following endocardial loss of Tie2 results in decreased endocardial sprouting required for trabecular assembly and extension. The hyperplastic trabeculae result from enhanced proliferation of trabecular cardiomyocytes, which is associated with upregulation of bone morphogenetic protein 10, increased retinoic acid (RA) signaling, and extracellular signal-regulated protein kinases 1 and 2 hyperphosphorylation in the myocardium. Intriguingly, myocardial phenotypes in conditional knockout hearts could be partially rescued by inhibiting in utero RA signaling with pan-RA receptor antagonist BMS493. These findings reveal 2 complementary functions of endocardial Tie2 during ventricular chamber formation: ensuring normal trabeculation by supporting endocardial cell proliferation and sprouting and preventing hypertrabeculation via suppression of RA signaling in trabecular cardiomyocytes.

Authors

Xianghu Qu, Cristina Harmelink, H. Scott Baldwin

×

Figure 6

Endocardial attenuation of Tie2 results in enhanced CM proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Endocardial attenuation of Tie2 results in enhanced CM proliferation.
(A...
(A and B) BrdU pulse labeling and coimmunostaining for BrdU (red) and troponin T (green) showing more BrdU-positive CMs (arrows) but fewer BrdU-positive ECs (arrowheads) in the trabecular zone of Tie2-cko embryos at E11.5 than those in the control group. (C) Quantification of BrdU-positive nuclei as a percentage of total nuclei in myocardium indicated that Tie2-cko displayed higher proliferation rates of CMs in the trabecular zone at E11.5 and E12.5 (n = 5 per group). **P < 0.01, 2-way ANOVA. (D and E) Compared with the control littermates (D), Bmp10 expression (red, in situ hybridization) in the trabecular CMs of Tie2-cko embryos (E) at E10.5 was enhanced. Endocardium was labeled with endomucin antibody (green). (F and G) Dual immunostaining of control and Tie2-cko heart sections for the cell cycle inhibitor p57 (red) and endomucin (green) at E11.5 showing significantly reduced p57 expression in the mutant endocardium. (H and I) Dual immunostaining of control and Tie2-cko heart sections for p-Erk1/2 (red) and CD31 (green) at E11.5 showing Erk1/2 hyperphosphorylation in the mutant trabecular myocardium. (J) Western blot analysis of E12.5 control and Tie2-cko hearts confirming significantly enhanced phosphorylation of Erk1/2 in the mutants. α-Tubulin was used as a loading control. Scale bars: 50 μm. For the studies in A–I, more than 5 embryos per genotype collected from at least 3 independent litters were analyzed. A representative of more than 10 images was chosen for each panel. For the studies in J, 58 embryonic hearts per genotype harvested from 23 independent litters were analyzed, and data are expressed as a representative of 3 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts